139 related articles for article (PubMed ID: 9384285)
1. Evaluation of a poliovirus-binding inhibition assay as an alternative to the virus neutralization test.
Herremans MM; Reimerink JH; Ras A; Van Der Avoort HG; Kimman TG; Van Loon AM; Conyn-Van Spaendonck MA; Koopmans MP
Clin Diagn Lab Immunol; 1997 Nov; 4(6):659-64. PubMed ID: 9384285
[TBL] [Abstract][Full Text] [Related]
2. Poliovirus-specific immunoglobulin A in persons vaccinated with inactivated poliovirus vaccine in The Netherlands.
Herremans MM; van Loon AM; Reimerink JH; Rümke HC; van der Avoort HG; Kimman TG; Koopmans MP
Clin Diagn Lab Immunol; 1997 Sep; 4(5):499-503. PubMed ID: 9302194
[TBL] [Abstract][Full Text] [Related]
3. Antibody responses to antigenic sites 1 and 3 of serotype 3 poliovirus after vaccination with oral live attenuated or inactivated poliovirus vaccine and after natural exposure.
Herremans T; Reimerink JH; Kimman TG; van Der Avoort HG; Koopmans MP
Clin Diagn Lab Immunol; 2000 Jan; 7(1):40-4. PubMed ID: 10618274
[TBL] [Abstract][Full Text] [Related]
4. Nasopharyngeal secretory antibody response to poliovirus type 3 virion proteins exhibit different specificities after immunization with live or inactivated poliovirus vaccines.
Zhaori G; Sun M; Faden HS; Ogra PL
J Infect Dis; 1989 Jun; 159(6):1018-24. PubMed ID: 2470831
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of an enzyme-linked immunosorbent assay based on binding inhibition for type-specific quantification of poliovirus neutralization-relevant antibodies.
Hashido M; Horie H; Abe S; Doi Y; Hashizume S; Agboatwalla M; Isomura S; Nishio O; Hagiwara A; Inouye S
Microbiol Immunol; 1999; 43(1):73-7. PubMed ID: 10100750
[TBL] [Abstract][Full Text] [Related]
6. Poliovirus-binding inhibition ELISA for evaluation of immune response to oral poliovirus vaccine: a possible alternative to the neutralization test.
Ivanov AP; Dragunsky EM; Ivanova OE; Rezapkin GV; Potapova SG; Chumakov KM
Hum Vaccin; 2005; 1(3):102-5. PubMed ID: 17012865
[TBL] [Abstract][Full Text] [Related]
7. Induction of mucosal immunity by inactivated poliovirus vaccine is dependent on previous mucosal contact with live virus.
Herremans TM; Reimerink JH; Buisman AM; Kimman TG; Koopmans MP
J Immunol; 1999 Apr; 162(8):5011-8. PubMed ID: 10202050
[TBL] [Abstract][Full Text] [Related]
8. Comparative evaluation of immunization with live attenuated and inactivated poliovirus vaccines.
Ogra PL
Ann N Y Acad Sci; 1995 May; 754():97-107. PubMed ID: 7625685
[TBL] [Abstract][Full Text] [Related]
9. Immunoglobulin a as a serological marker for the (silent) circulation of poliovirus in an inactivated poliovirus-vaccinated population.
Herremans T; Kimman TG; Conyn-Van Spaendonck MA; Buisman A; de Melker H; Abbink F; Bijkerk P; Koopmans MP
Clin Infect Dis; 2002 Apr; 34(8):1067-75. PubMed ID: 11914995
[TBL] [Abstract][Full Text] [Related]
10. Enzyme-linked immunosorbent assay-based inhibition test for neutralizing antibodies to polioviruses as an alternative to the neutralization test in tissue culture.
Edevåg G; Wahren B; Osterhaus AD; Sundqvist VA; Granström M
J Clin Microbiol; 1995 Nov; 33(11):2927-30. PubMed ID: 8576347
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity of a supplemental dose of oral versus inactivated poliovirus vaccine.
Moriniere BJ; van Loon FP; Rhodes PH; Klein-Zabban ML; Frank-Senat B; Herrington JE; Pallansch MA; Patriarca PA
Lancet; 1993 Jun; 341(8860):1545-50. PubMed ID: 8099637
[TBL] [Abstract][Full Text] [Related]
12. Poliovirus-binding inhibition ELISA based on specific chicken egg yolk antibodies as an alternative to the neutralization test.
Ivanov AP; Klebleyeva TD; Malyshkina LP; Ivanova OE
J Virol Methods; 2019 Apr; 266():7-10. PubMed ID: 30660606
[TBL] [Abstract][Full Text] [Related]
13. Long-term evaluation of mucosal and systemic immunity and protection conferred by different polio booster vaccines.
Xiao Y; Daniell H
Vaccine; 2017 Sep; 35(40):5418-5425. PubMed ID: 28111147
[TBL] [Abstract][Full Text] [Related]
14. Global eradication of poliomyelitis: reinvent the wheel or use existing options effectively?
Ogra PL
Public Health Rev; 1993-1994; 21(1-2):143-50. PubMed ID: 8041881
[TBL] [Abstract][Full Text] [Related]
15. Comparative evaluation of immunization with live attenuated and enhanced-potency inactivated trivalent poliovirus vaccines in childhood: systemic and local immune responses.
Faden H; Modlin JF; Thoms ML; McBean AM; Ferdon MB; Ogra PL
J Infect Dis; 1990 Dec; 162(6):1291-7. PubMed ID: 2172403
[TBL] [Abstract][Full Text] [Related]
16. An Introduction to Poliovirus: Pathogenesis, Vaccination, and the Endgame for Global Eradication.
Minor PD
Methods Mol Biol; 2016; 1387():1-10. PubMed ID: 26983727
[TBL] [Abstract][Full Text] [Related]
17. A novel multiplex poliovirus binding inhibition assay applicable for large serosurveillance and vaccine studies, without the use of live poliovirus.
Schepp RM; Berbers GA; Ferreira JA; Reimerink JH; van der Klis FR
J Virol Methods; 2017 Mar; 241():15-23. PubMed ID: 27988324
[TBL] [Abstract][Full Text] [Related]
18. Surveillance of immunity acquired from poliovirus immunization including vaccination with the Sabin strain-derived inactivated vaccine.
Hotta C; Ogawa T; Shirasawa H
Hum Vaccin Immunother; 2019; 15(5):1154-1159. PubMed ID: 30676843
[TBL] [Abstract][Full Text] [Related]
19. Inactivated poliovirus vaccine given alone or in a sequential schedule with bivalent oral poliovirus vaccine in Chilean infants: a randomised, controlled, open-label, phase 4, non-inferiority study.
O'Ryan M; Bandyopadhyay AS; Villena R; Espinoza M; Novoa J; Weldon WC; Oberste MS; Self S; Borate BR; Asturias EJ; Clemens R; Orenstein W; Jimeno J; Rüttimann R; Costa Clemens SA;
Lancet Infect Dis; 2015 Nov; 15(11):1273-82. PubMed ID: 26318714
[TBL] [Abstract][Full Text] [Related]
20. Humoral and mucosal immunity in infants induced by three sequential inactivated poliovirus vaccine-live attenuated oral poliovirus vaccine immunization schedules. Baltimore Area Polio Vaccine Study Group.
Modlin JF; Halsey NA; Thoms ML; Meschievitz CK; Patriarca PA
J Infect Dis; 1997 Feb; 175 Suppl 1():S228-34. PubMed ID: 9203721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
